Analysis of circulating adipokines in patients newly diagnosed with solid cancer: Associations with measures of adiposity and tumor characteristics.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Oncology Letters

• Publication date

  2017-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3892/ol.2017.5670PMID 28454352PMCID PMC5403199
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer statistics, 2016

  2016cited by this paper
• Evaluation of diagnostic and predictive value of serum adipokines: Leptin, resistin and visfatin in postmenopausal breast cancer.

  2016cited by this paper
• Obesity and Breast Cancer: Molecular and Epidemiological Evidence

  2015cited by this paper
• Concise Review: The Obesity Cancer Paradigm: Exploration of the Interactions and Crosstalk with Adipose Stem Cells

  2015cited by this paper
• Obesity, adipokines and cancer: an update

  2015cited by this paper
• Association between adiponectin levels and endometrial carcinoma risk: evidence from a dose–response meta-analysis

  2015cited by this paper
• Circulating Leptin and Risk of Pancreatic Cancer: A Pooled Analysis From 3 Cohorts.

  2015cited by this paper
• Circulating adiponectin, leptin and adiponectin–leptin ratio and endometrial cancer risk: Evidence from a meta‐analysis of epidemiologic studies

  2015cited by this paper
• Visceral Obesity Predicts Fewer Lymph Node Metastases and Better Overall Survival in Colon Cancer

  2015cited by this paper
• Relationship between serum leptin levels and non-small cell lung carcinoma: a meta-analysis.

  2015cited by this paper
• Leptin signalling, obesity and prostate cancer: molecular and clinical perspective on the old dilemma

  2015cited by this paper
• Low anthropometric measures and mortality—results from the Malmö Diet and Cancer Study

  2015cited by this paper
• Statistical atlas construction via weighted functional boxplots

  2014cited by this paper
• Association between chemotherapy and plasma adipokines in patients with colorectal cancer

  2014cited by this paper
• Adiponectin Receptor Expression Predicts Favorable Prognosis in Cases of Hepatocellular Carcinoma

  2014cited by this paper
• Leptin increases HER2 protein levels through a STAT3‐mediated up‐regulation of Hsp90 in breast cancer cells

  2013cited by this paper
• Obesity, insulin resistance, adipocytokines and breast cancer: New biomarkers and attractive therapeutic targets.

  2013cited by this paper
• Adipocytes: impact on tumor growth and potential sites for therapeutic intervention.

  2013cited by this paper
• Obesity as an Important Risk Factor for Certain Types of Cancer

  2013cited by this paper
• The emerging role of MET/HGF inhibitors in oncology.

  2013cited by this paper
• Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells

  2013cited by this paper
• Breast Cancer and Obesity: In Vitro Interferences between Adipokines and Proangiogenic Features and/or Antitumor Therapies?

  2013cited by this paper
• Hepatocyte growth factor and interferon‐γ inducible protein‐10 are related to visceral adiposity

  2013cited by this paper
• Mechanics behind breast cancer prevention - focus on obesity, exercise and dietary fat.

  2013cited by this paper
• Role of Adiponectin and Its Receptors in Cancer

  2012cited by this paper
• Met Kinetic Signature Derived from the Response to HGF/SF in a Cellular Model Predicts Breast Cancer Patient Survival

  2012cited by this paper
• New insights into anticarcinogenic properties of adiponectin: a potential therapeutic approach in breast cancer?

  2012cited by this paper
• Adipose tissue quantity and composition contribute to adipokine concentrations in the subclavian vein and the inferior mesenteric vein

  2012cited by this paper
• Leptin regulates proliferation and apoptosis of colorectal carcinoma through PI3K/Akt/mTOR signalling pathway

  2012cited by this paper
• Energy Balance Modulates Mouse Skin Tumor Promotion through Altered IGF-1R and EGFR Crosstalk

  2012cited by this paper
• The role of adiponectin in cancer: a review of current evidence.

  2012cited by this paper
• The balance between leptin and adiponectin in the control of carcinogenesis - focus on mammary tumorigenesis.

  2012cited by this paper
• Design and development of a peptide-based adiponectin receptor agonist for cancer treatment

  2011cited by this paper
• The Aromatase Gene (CYP19A1) Variants and Circulating Hepatocyte Growth Factor in Postmenopausal Women

  2011cited by this paper
• Leptin increases motility and integrin up‐regulation in human prostate cancer cells

  2011cited by this paper
• Obesity, type 2 diabetes and risk of digestive cancer.

  2010cited by this paper
• Appropriateness of waist circumference and waist-to-hip ratio cutoffs for different ethnic groups

  2010cited by this paper
• MET molecular mechanisms and therapies in lung cancer

  2010cited by this paper
• New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

  2009cited by this paper
• The MET axis as a therapeutic target.

  2009cited by this paper
• Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As

  2009cited by this paper
• Dual MET–EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer

  2008cited by this paper
• The significance of leptin, adiponectin, and resistin serum levels in non-small cell lung cancer (NSCLC).

  2008cited by this paper
• Leptin/HER2 crosstalk in breast cancer: in vitro study and preliminary in vivo analysis

  2008cited by this paper
• Obesity and Risk of Colorectal Cancer: A Meta-analysis of 31 Studies with 70,000 Events

  2007cited by this paper
• Epidemiology and pathophysiology of obesity as cause of cancer.

  2007cited by this paper
• Intra-individual Variation of Plasma Adipokine Levels and Utility of Single Measurement of These Biomarkers in Population-Based Studies

  2007cited by this paper
• Effects of leptin on human breast cancer cell lines in relationship to estrogen receptor and HER2 status.

  2007cited by this paper
• Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression.

  2007cited by this paper
• Angiogenic factors are elevated in overweight and obese individuals

  2005cited by this paper
• Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans.

  2004cited by this paper
• Regulation of fatty acid transport by fatty acid translocase/CD36

  2004cited by this paper
• Secretion of Angiogenic and Antiapoptotic Factors by Human Adipose Stromal Cells

  2004cited by this paper
• Central obesity and breast cancer risk: a systematic review

  2003cited by this paper
• Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation

  2003cited by this paper
• Obesity is associated with increased levels of circulating hepatocyte growth factor.

  2003cited by this paper
• Obesity: preventing and managing the global epidemic. Report of a WHO consultation.

  2000cited by this paper
• Annals of the New York Academy of Sciences Obesity and Cancer Risk: Evidence, Mechanisms, and Recommendations

  year unknowncited by this paper

• Altered Serum Marker of Adipokines Profile in Breast Cancer Women

  2021cites this paper
• High levels of leptin and non-high molecular weight-adiponectin in patients with colorectal cancer: Association with chemotherapy and common genetic polymorphisms.

  2020cites this paper
• Differentially expressed genes SNRPC and PRPF38A are potential biomarkers candidates for osteosarcoma

  2020cites this paper
• Immunostaining characteristics of irisin in benign and malignant renal cancers

  2019cites this paper
• Leptin stimulates the epithelial‑mesenchymal transition and pro‑angiogenic capability of cholangiocarcinoma cells through the miR‑122/PKM2 axis.

  2019cites this paper
• Adipose Tissue Metabolism and Cancer Progression: Novel Insights from Gut Microbiota?

  2017cites this paper